FDA flags cancer-causing impurity in common heartburn drugs

The FDA is warning patients and healthcare providers that some ranitidine medicines, common heartburn drugs, contain a potentially cancer-causing impurity. 

The rantitide drugs were found to contain N-nitrosodimethylamine, classified as a probable human carcinogen.

The FDA warned that Sanofi's popular brand-name drug Zantac was one of the drugs known to contain this impurity. Ranitidine is a histamine-2 blocker, which decreases the amount of acid created by the stomach. Ranitidine is both an over-the-counter and prescription drug. 

News of the impurity in a new drug comes as r the FDA has been investigating NDMA and other nitrosamine impurities in blood pressure and heart failure medicines for more than a year.  Hundreds of blood pressure medications have been recalled as a result. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars